Search documents
HR tech firm Rippling raises new funding at $16.8 billion valuation, no IPO plans
Reuters· 2026-05-09 17:02AI Processing
Core Insights - Rippling, an HR software startup, raised $450 million in Series G funding, achieving a valuation of $16.8 billion, focusing on global revenue growth over immediate profitability [1][4][5] Funding and Valuation - The funding round included participation from notable investors such as Y Combinator, Elad Gil, Sands Capital, GIC, and Goldman Sachs Growth [2] - The new valuation of $16.8 billion marks an increase from the previous valuation of $13.5 billion in early 2024 [4] Employee Equity and IPO Plans - Rippling plans to repurchase up to $200 million of equity from current and former employees through a tender offer, which may become an annual event [2][3] - The CEO stated that the company does not have immediate plans for an IPO, emphasizing the need for profitability before considering going public [4][6] Business Performance and Strategy - Rippling has surpassed $100 million in annual recurring revenue and serves over 20,000 customers with a suite of more than 20 products [5] - The company is prioritizing growth over profitability, indicating a strategic choice to expand rapidly rather than slow down for immediate profit [6] Legal Challenges - Rippling is involved in ongoing legal disputes with competitor Deel, including allegations of corporate espionage, which have raised questions about competitive practices in the tech industry [7][8]
AAR Corp (NYSE:AIR) Insider Sale, Strategic Merger, and Strong Q3 Financials
Financial Modeling Prep· 2026-03-30 21:02
Insider Activity: Holmes John McClain III, Chairman, President, and CEO, sold 23,950 shares but retains a significant stake, signaling ongoing leadership commitment. Strategic Developments: AIR Limited advances its Nasdaq listing through a merger and SEC filing, positioning itself for growth in the U.S. market. Robust Financial Performance: AAR Corp reported a 25% increase in total sales and a 31% rise in adjusted operating income for Q3 2026, with strong institutional investor confidence.On March 27, 2026 ...
Progress(PRGS) - 2026 Q1 - Earnings Call Presentation
2026-03-30 21:00
Q1 2026 Supplemental Information Progress Financial Results March 30, 2026 Forward Looking Statements This presentation contains statements that are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Progress has identified some of these forward-looking statements with words like "believe," "may," "could," "would," "might," "should," "expect," "intend," "plan," "target," "anticipate" an ...
Innventure, Inc.(INV) - 2025 Q4 - Earnings Call Presentation
2026-03-30 21:00
Fourth Quarter and Full Year 2025 Earnings March 30, 2026 Disclaimer The material that follows is a presentation ("Presentation") of information about Innventure, Inc. and its subsidiaries (together referred to herein as "Innventure," the "Company," "us," "our," or "we") as of the date of this presentation. The Presentation does not purport to contain all information that may be required or desired by a party interested in investigating the Company, its business or prospects, and it shall not be deemed to b ...
Phreesia(PHR) - 2026 Q4 - Earnings Call Presentation
2026-03-30 21:00
The Company's financial results for the fiscal quarter and fiscal year ended January 31, 2026 reflect inclusion of the business operations of AccessOne from November 12, 2025. The post-acquisition results reflect only a partial period and include integration-related costs and therefore are not indicative of AccessOne's full-quarter or full-year performance. Investor Presentation FOURTH QUARTER | FISCAL YEAR 2026 Disclaimer This presentation includes express or implied statements that are not historical fact ...
Clorox: A Clean Portfolio Holding Through Market Volatility
Seeking Alpha· 2026-03-30 20:37
Analyst's Disclosure: I/we have a beneficial long position in the shares of CLX either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any in ...
What The Market Got Wrong With Uber (Rating Upgrade)
Seeking Alpha· 2026-03-30 20:33
Uber Technologies, Inc. ( UBER ) is back on my radar after the recent pullback. The stock has been in limbo for the past few months, down over 15% year-to-date and touching a recent low of $68.40I’m a retired Wall Street PM specializing in TMT; since kickstarting my career, I’ve spent over two decades in the market navigating the technology landscape, focusing on risk mitigation through the dot com bubble, credit default of ‘08, and, more recently, with the AI boom. In one word, what I’d like my service to ...
GEMI INVESTOR ALERT: Hagens Berman Alerts Gemini Space Station (GEMI) Investors to Securities Class Action Following 75% Post-IPO Collapse
Prnewswire· 2026-03-30 20:31
GEMI INVESTOR ALERT: Hagens Berman Alerts Gemini Space Station (GEMI) Investors to Securities Class Action Following 75% Post- IPO Collapse Accessibility StatementSkip Navigation Lawsuit Alleges IPO Documents Concealed Impending "Corporate Pivot" and Executive Turmoil; Firm Reminds Investors of May 18 Lead Plaintiff Deadline SAN FRANCISCO, March 30, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is notifying investors that a securities class action lawsuit has been filed against ...
Saia to Announce First Quarter 2026 Results on April 30, 2026
Globenewswire· 2026-03-30 20:30
JOHNS CREEK, Ga., March 30, 2026 (GLOBE NEWSWIRE) -- Saia, Inc. (Nasdaq: SAIA) announced that it will release its quarterly financial results before the market opens on Thursday, April 30th. Saia management will host a conference call to discuss the results later that morning at 10:00 a.m. Eastern Time. To participate in the call, please dial 1-833-890-5317 and request to join the Saia, Inc. call. Callers should dial in five to ten minutes in advance of the conference call. This call will be webcast live vi ...
Sangamo Therapeutics(SGMO) - 2025 Q4 - Earnings Call Presentation
2026-03-30 20:30
Delivering the Future of Genomic Medicines March 30, 2026 Forward-Looking Statements and Legal Disclaimers This presentation, and accompanying oral commentary, contains forward-looking statements regarding our current expectations. These forward-looking statements include, without limitation, statements relating to: the therapeutic and commercial potential and value of our product candidates and engineered capsids, including the ability of our zinc finger epigenetic regulators to address various neurologica ...